Summit of the Americas on Immunotherapies for Hematologic Malignancies, Second Annual

May 14, 2021

Live Virtual Symposium - May 14, 2021

ENROLL Today →

Given the increasing frequency of hematologic malignancies, complexities of treatments with novel agents and particularly with immunotherapeutic approaches, there is a need to provide an opportunity for oncologists, hematologists, oncology nurses and pharmacists to engage in a thoughtful discussions with experts in these fields. In addition, there is emerging data about the biology of these malignancies impacting optimal management of patients with these disorders. Clinical decision making and management therefore have become more complex.

This year’s meeting will be a half-day virtual symposium designed to provide an overview and opportunity to learn about the most recent advances in the treatment of leukemia, lymphoma, multiple myeloma and stem cell transplantation by novel immunotherapies and treatment combinations. Updates on evolving immunologically and molecular based system therapies will be profiled and discussed.

Topics This Year

  • Novel Developments in CAR T-cell therapies
  • GPS-guided CAR T-cell therapies
  • Updates on indications for allogeneic stem transplants in the era of CARS
  • BCMA targeted therapies for multiple myeloma
  • Treatment approaches for multiple myeloma

Educational Objectives

Upon completion of this symposium, participants should be better able to:

  • Summarize the evolving therapeutic strategies in the treatment of hematologic malignancies.
  • Provide an update of new molecular and immunological treatments being developed for these diseases.
  • Discuss the rationale for new targeted diagnostic and therapeutic strategies for lymphoma, myeloma and leukemia.
  • Review the role and timing of hematopoietic cell transplantation and potential combinations of immunotherapeutic treatment options.

Who Should Attend

This educational program is directed toward hematologists, oncologists, pathologists, radiation oncologists, palliative care staff, medical oncologist, hematology nurses, pharmacists and other allied health care professionals interested in the treatment of patients with hematologic malignancies.

Registration and Fees

This live virtual symposium is offered free of charge.

Event date: May 14, 2021

ENROLL Today →

Course Summary
Available credit: 
  • 3.25 AMA PRA Category 1 Credit™
  • 3.25 General certificate of attendance
  • 3.20 Florida Board of Laboratory Personnel
  • 3.00 Nurse Practitioners
  • 3.00 Florida Board of Nursing
  • 3.25 Florida Board of Pharmacy
Course opens: 
Course expires: 
Event starts: 
05/14/2021 - 9:00am EDT
Event ends: 
05/14/2021 - 12:30pm EDT


9:00 - 9:10 a.m.Welcome and Introductions
Guenther Koehne, M.D., Ph.D.
 Acute Lymphoid Leukemia
9:10 - 9:30 a.m.Updates on Treatment Approaches for Acute Lymphoblastic Leukemia
Wendy Stock, M.D.
 Acute Myeloid Leukemia
9:30 - 9:50 a.m.Updates on Treatment Approaches for High-Risk AML
Richard Stone, M.D.
9:50 - 10:05 a.m.Questions and Answers
10:05 - 10:10 a.m.Break
 Multiple Myeloma
10:10 - 10:30 a.m.Updates on Treatment Approaches for Multiple Myeloma
Paul Richardson, M.D.
10:30 - 10:50 a.m.Updates on BCMA-Targeted Therapies for Multiple Myeloma
Adam Cohen, M.D.
 Allogeneic Stem Cell Transplants
10:50 - 11:10 a.m.Updates on Indications for Allogeneic Stem Transplants in the Era of CARs
Robert Soiffer, M.D.
11:10 - 11:25 a.m.Questions and Answers
11:25 - 11:30 a.m.Break
 CAR Cell Therapies
11:30 - 11:50 a.m.GPS-Guided CAR T-cell Therapies
Robert Sackstein, M.D., Ph.D.
11:50 a.m. - 12:10 p.m.Do CARs Always Have to Be T Cells?
Paul Lin, M.D.
12:10 - 12:30 p.m.Questions and Answers
12:30 p.m.Adjourn

NOTE: Schedule subject to change.

Symposium Director

Guenther Koehne M.D., Ph.D.Guenther Koehne M.D., Ph.D.
Deputy Director of Miami Cancer Institute
Chief of Blood & Marrow Transplant and Hematologic Oncology
Miami Cancer Institute
Miami, Florida 


Adam D. Cohen, M.D.Adam D. Cohen, M.D.
Associate Professor of Medicine
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania
Paul Lin M.D., Ph.D.Paul Lin M.D., Ph.D.
Instructor at The University of Texas
MD Anderson Cancer Center
Houston, Texas
Paul Richardson, M.D.Paul Richardson, M.D.
Clinical Program Leader and Director
Of Clinical Research
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
RJ Corman Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Robert Sackstein, M.D.Robert Sackstein, M.D.
Senior Vice President for Health Affairs
Dean, Herbert Wertheim College of Medicine
Florida International University
Miami, Florida
Robert Soiffer, M.D.Robert Soiffer, M.D.
Chief, Division of Hematologic Malignancies
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Wendy Stock, M.D.Wendy Stock, M.D.
Hematologist/ Oncologist
Professor of Medicine
University of Chicago
Chicago, Illinois
Richard M. Stone, M.D.Richard M. Stone, M.D.
Chief of Staff, Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Disclosures And Resolution Of Conflict Of Interest

Disclosure Policy and Disclaimer


Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for 3.25 credit hours, CE Broker Course #20-840870, by the Florida Boards of Medicine, Osteopathic Medicine, and by the Florida Council of Physician Assistants.

This activity has also been approved for 3 credits for Nursing, 3.25 credits for Pharmacy, and 3.20 credits for Laboratory (hematology). Baptist Health South Florida CE Broker Provider #50-182.

The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.

AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.


Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.

While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use. ​​

Available Credit

  • 3.25 AMA PRA Category 1 Credit™
  • 3.25 General certificate of attendance
  • 3.20 Florida Board of Laboratory Personnel
  • 3.00 Nurse Practitioners
  • 3.00 Florida Board of Nursing
  • 3.25 Florida Board of Pharmacy
Please login or register for a Baptist Health CME account to take this course.

The Summit of the Americas on Immunotherapies for Hematologic Malignancies will be a fully virtual symposium, allowing learners to access high-quality content and engage remotely from around the world in a platform that has been designed explicitly for this meeting.

Compatibility Notice

Google Chrome is recommended to access the live stream to ensure the best experience and optimal connectivity. NOTE: Live streaming is not compatible with Internet Explorer (IE).